Skip to content
Assyro AI
510(k) Predicate Database
FDA 510(k) ClearanceGCJ

EZ-Close™ (EZ Close Port Site Closing Device, EZ Close MAX Port Site Closing Device, EZ Close II Port Site Closing Device)

FDA 510(k) K253541 · Medical Impact

510(k) number
K253541
Device name
EZ-Close™ (EZ Close Port Site Closing Device, EZ Close MAX Port Site Closing Device, EZ Close II Port Site Closing Device)
Applicant
Medical Impact
Product code
GCJ
Decision
Substantially Equivalent
Decision date
Device class
Class 2
Regulation number
876.1500
Advisory committee
SU
Medical specialty
Gastroenterology, Urology

Candidate predicate devices

Other devices cleared under product code GCJ form a screening cohort, not a predicate determination. Compare intended use, technological characteristics, performance evidence, labeling, and current legal-marketing status before selecting a predicate.

Candidate predicate devices for K253541
510(k)DeviceApplicantDecision date
K261614LED LCD Monitor (OEV-271H)Lg Electronics.Inc
K261249Universal Seal (5-12 mm)Intuitive Surgical, Inc.
K260710FloShield Air System (FSS-01-1000T - 10mm, 0 Degree FloShield Air, FSS-02-1030T - 10mm, 30 Degree FloShield Air, FSS-03-1045T - 10mm, 45 Degree FloShield Air, FSS-01-0500T - 5mm, 0 Degree FloShield Air, FSS-02-0530T - 5mm, 30 Degree FloShield Air, FSS-01-0545T - 5mm, 45 Degree FloShield Air)FloShield, Inc.
K260414“Tech-Image” Video Endoscope SystemTech-Image CO., LTD.
K253994TroKit Laparoscope Lens WiperTroCare, LLC
K252532Inno-Port Disposable Bladed TrocarTaiwan Surgical Corporation
K2603184K NIR/ICG Imaging SystemZhejiang Healnoc Technology Co., Ltd.
K260183MediBot Needle Driver UnoParallel Robotics, LLC
K252985LaportSejong Medical Co., Ltd.
K254228KARL STORZ Trocars with Valve SealsKarl Storz SE & CO. KG
K2528584K UHD Endoscopy Camera System (KMS-4K-2088, KMS-4K-2188, KMS-4K-2288)Kms Medical Technology Co., Ltd.

Building a 510(k) around this device type?

Assyro turns predicate research into a substantial-equivalence comparison and an eSTAR-ready 510(k) workflow — so predicate strategy, testing evidence, and labeling stay aligned before FDA review.